Last reviewed · How we verify
NCT06281613
Comparison of AMCOP Bioactivator and High-pull Headgear in Treating Skeletal Class II Hyperdivergent Pediatric Patients
trial testing AMCOP group in Skeletal Malocclusion in 40 participants. Completed in 30 April 2024.
26 April 2024
Quick facts
| Lead sponsor | University of Pavia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 3 March 2024 |
| Primary completion | 26 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- AMCOP group
- High-pull headgear
Conditions studied
- Skeletal Malocclusion — all drugs for Skeletal Malocclusion →
Sponsor
University of Pavia
Who can join
Adults 7 to 11, any sex, with Skeletal Malocclusion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the present study was to retrospectively compare the clinical use of high-pull headgear versus AMCOP bioactivators for hyperdivergent pediatric patients. Cephalometric radiographs from pediatric patients treated at the Unit of Orthodontics and Pediatric Dentistry, Section of Dentistry, Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy and at the private practice of Dr. Cardarelli, Isernia, Italy will be collected. Cephalometric tracing from Giannì analysis will be performed at the baseline (T0) and after 18 months of treatment (T1).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluation of an Elastodontic Bioactivator Versus High-Pull Headgear for the Treatment of Skeletal Class II Hyperdivergent Pediatric Patients: A Retrospective Study.
Sfondrini MF, Pascadopoli M, Nardi MG, Cardarelli F, et al · · 2026 · PMID 41598741 · DOI 10.3390/jcm15020804
Verify or expand the search:
- PubMed search for NCT06281613
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University of Pavia trials
Trials by the same sponsor.
- NCT07491536 — Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis · NA · recruiting
- NCT07421128 — The Pause, Learn, and Activate Yourself (PLAY) · NA · not yet recruiting
- NCT07199712 — Ozone Therapy for Oral Mucositis in Patients Receiving Head and Neck Cancer Radio- and Chemotherapy · NA · completed
- NCT07088653 — Comparison of 0.12% Chlorhexidine and MicroRepair ABX Mouthwash in Gingivitis Management · NA · completed
- NCT07140146 — Trehalose vs Glycine Air-Polishing in Peri-Implant Mucositis Treatment · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06281613 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Pavia
- Last refreshed: 23 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06281613.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing